Member Comments are provided by individuals and reflect their personal opinions only. Under NO circumstances should you act on any advice or opinion posted in this forum. ALWAYS check with your personal physician before taking any action regarding your health! MedHelp International and our partners, sponsors and affiliates have no obligation to monitor any comments posted on this site, or the content and/or accuracy of such exchanges. MedHelp International does not endorse the views of any user.
Recent articles on HCV
by DRAGON SLAYER, Oct 09, 2005 12:00AM
Latest articles about Hepatitis C in
http://www.natap.org/
HCV Section
Increased Rates of Liver Cell Death in HCV/HIV Coinfection - (10/07/05)
Didanosine plus ribavirin can be toxic in HIV patients treated for hepatitis C - (10/07/05)
Toll-Like Receptors: new therapy to stimulate immune system - (10/06/05)
Increased Rates of Liver Cell Death in HCV/HIV Coinfection - (10/05/05)
Biomarkers used to predict recurrent disease in hepatitis C transplant patients - (10/05/05)
24 Week PegIntron/RBV Therapy Approved in Europe for HCV Genotype 1 & Low Viral Load - (10/05/05)
Presence of Hepatitis C Virus (HCV) RNA in the Genital Tracts of HCV/HIV-1-Coinfected Women - (10/05/05)
Undetectable HIV May Slow Fibrosis in HCV/HIV Coinfected Patients - (10/04/05)
New HCV Antisense Drug - (10/04/05)
Hepatitis C Vaccine Candidate - (10/04/05)
Two New HCV Polymerase Inhibitors: early study data show potency & perhaps once daily dosing - (10/04/05)
New HCV Drug NM283 HBV Drug LdT at AASLD - (10/03/05)
New HCV Protease Inhibitor VX-950 - (10/03/05)
Hepatitis C and liver transplantation - (10/03/05)
Breakthrough for HCV research: in vitro HCV replication - (10/03/05)
Asians 'risk fatal liver disease' - (10/03/05)
New HCV & HBV Drugs: XTL-6865, XTL2125 - (09/30/05)
Britain 'failing' on hepatitis C - (09/30/05)
Hepatitis C: Current approaches in pediatrics - (09/30/05)
Noninvasive Fibrosis Test Performs Well - (09/30/05)
New Toll-like Receptor Drug Acti
http://www.natap.org/
HCV Section
Increased Rates of Liver Cell Death in HCV/HIV Coinfection - (10/07/05)
Didanosine plus ribavirin can be toxic in HIV patients treated for hepatitis C - (10/07/05)
Toll-Like Receptors: new therapy to stimulate immune system - (10/06/05)
Increased Rates of Liver Cell Death in HCV/HIV Coinfection - (10/05/05)
Biomarkers used to predict recurrent disease in hepatitis C transplant patients - (10/05/05)
24 Week PegIntron/RBV Therapy Approved in Europe for HCV Genotype 1 & Low Viral Load - (10/05/05)
Presence of Hepatitis C Virus (HCV) RNA in the Genital Tracts of HCV/HIV-1-Coinfected Women - (10/05/05)
Undetectable HIV May Slow Fibrosis in HCV/HIV Coinfected Patients - (10/04/05)
New HCV Antisense Drug - (10/04/05)
Hepatitis C Vaccine Candidate - (10/04/05)
Two New HCV Polymerase Inhibitors: early study data show potency & perhaps once daily dosing - (10/04/05)
New HCV Drug NM283 HBV Drug LdT at AASLD - (10/03/05)
New HCV Protease Inhibitor VX-950 - (10/03/05)
Hepatitis C and liver transplantation - (10/03/05)
Breakthrough for HCV research: in vitro HCV replication - (10/03/05)
Asians 'risk fatal liver disease' - (10/03/05)
New HCV & HBV Drugs: XTL-6865, XTL2125 - (09/30/05)
Britain 'failing' on hepatitis C - (09/30/05)
Hepatitis C: Current approaches in pediatrics - (09/30/05)
Noninvasive Fibrosis Test Performs Well - (09/30/05)
New Toll-like Receptor Drug Acti
Post Comment
Related Communities
Recent Videos
Related Expert Forums
Recent Activity
Most Popular Trackers
RSS
Expert Activity
Community Members
Popular Groups
Psych Impairment in Coinfected Women - (09/29/05)
Flamel Technologies Announces Positive Preliminary Results of a Phase I/II Trial of IFN-alpha-XL in Patients with Chronic Hepatitis C Virus Infection - (09/29/05)
Chronic Hepatitis C in Latinos: Natural History, Treatment Eligibility, Acceptance, and Outcomes - (09/29/05)
MIGENIX Completes First Clinical Study of Celgosivir in Chronic Hepatitis C Patients - (09/29/05)
Bioenvision's Phase II Trial of Virostat Very Active in Hepatitis C - (09/29/05)
New Hep C Protease Inhibitor - (09/21/05)
Liver Injury and Changes in Hepatitis C Virus (HCV) RNA Load Associated with Protease Inhibitor-Based Antiretroviral Therapy for Treatment-Naive HCV-HIV-Coinfected Patients: Lopinavir-Ritonavir versus Nelfinavir - (